Rituximab Clinical Trials in Hangzhou, Zhejiang
2 recruitingHangzhou, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
ZR2 Sequential Immunochemotherapy for Newly Treated MCL
Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma
Zhejiang Cancer Hospital48 enrolled1 locationNCT05992597
Recruiting
Phase 3
Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial
Nephrotic Syndrome in ChildrenRituximab
The Children's Hospital of Zhejiang University School of Medicine80 enrolled1 locationNCT05734794